Cochrane Abstracts
Electroconvulsive therapy for preventing relapse and recurrence in people with depression
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Electroconvulsive Therapy for Preventing Relapse and Recurrence in People With Depression." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434730/all/Auranofin_versus_placebo_in_rheumatoid_arthritis:_Cochrane_systematic_review. Accessed 20 April 2024.
Electroconvulsive therapy for preventing relapse and recurrence in people with depression. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434730/all/Auranofin_versus_placebo_in_rheumatoid_arthritis:_Cochrane_systematic_review. Accessed April 20, 2024.
Electroconvulsive therapy for preventing relapse and recurrence in people with depression. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434730/all/Auranofin_versus_placebo_in_rheumatoid_arthritis:_Cochrane_systematic_review
Electroconvulsive Therapy for Preventing Relapse and Recurrence in People With Depression [Internet]. In: Cochrane Abstracts. [cited 2024 April 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434730/all/Auranofin_versus_placebo_in_rheumatoid_arthritis:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Electroconvulsive therapy for preventing relapse and recurrence in people with depression
ID - 434730
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434730/all/Auranofin_versus_placebo_in_rheumatoid_arthritis:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
